You are here

hemophilia

Sharp knives and hemophilia? No problem in Roche's new work-life miniseries

Fierce Pharma

Fri, 09/11/20 - 10:51 am

pharma marketing

Sanofi's hemophilia drug comes into focus as delays hit a key competitor

BioPharma Dive

Thu, 09/10/20 - 11:19 pm

Novo gets PhIII hemophilia trials for a Roche rival back on track after completing work-around on blood clot threat

Endpoints

Thu, 08/13/20 - 09:48 am

clinical trials

Sangamo R&D chief hits the exit as it splits R&D into separate units

Fierce Biotech

Thu, 06/25/20 - 10:35 am

Sigilon picks up $80M to test hemophilia cell therapy in humans

Fierce Biotech

Sat, 03/21/20 - 02:02 pm

Siglion Therapeutics

Novo Nordisk Pauses 3 Clinical Trials Testing Hemophilia Therapy

Xconomy

Mon, 03/16/20 - 11:50 pm

clinical trials

BioMarin Considers $3 Million Price Tag for New Hemophilia Gene Therapy

Motley Fool

Thu, 01/16/20 - 11:27 pm

BioMarin sets gene therapy sights beyond hemophilia

BioPharma Dive

Mon, 01/13/20 - 11:40 pm

Value-based pricing for gene therapy? Maybe not ready for hemophilia

Biopharma Dive

Thu, 12/12/19 - 10:52 am

valoctocogene roxaparvovec

Sangamo keeps pressure on rivals with updated hemophilia data

Biopharma Dive

Sat, 12/7/19 - 11:48 pm

Why Novo Nordisk should buy Uniqure

EP Vantage

Fri, 10/11/19 - 10:31 am

The return of Vioxx: Can a drug once deemed deadly be relaunched to treat rare disease?

Stat

Wed, 10/9/19 - 10:05 am

Tremeau Pharmaceuticals

hemophilic arthropathy

Novo taps bluebird bio for gene-editing tech

Fierce Biotech

Wed, 10/9/19 - 09:43 am

BioMarin drops lower dose of its hemophilia gene therapy as it eyes submissions by year-end

Fierce Biotech

Fri, 08/2/19 - 10:37 am

valoctocogene roxaparvovec

Thrashed by a 'surprise' rival, Sanofi writes off $2B on soured hemophilia deal

Endpoints

Mon, 07/29/19 - 09:39 am

Pharmacquired: Is $11B enough to secure Sanofi's spot in hemophilia?

Biopharma Dive

Thu, 06/20/19 - 10:04 am

Sangamo Stock Soars on Positive Hemophilia Treatment Trial

TheStreet.com

Tue, 04/2/19 - 11:59 am

Sangamo BioSciences

clinical trials

IP trouble defers launch of Novo's long-acting hemophilia therapy

Endpoints

Wed, 02/20/19 - 10:03 am

FDA hemophilia meeting to discuss new efficacy endpoints

BioCentury

Fri, 11/2/18 - 09:15 am

clinical trials

Genentech and Hemophilia Patients Eye Oct. 4 for Hemlibra Ruling

BioSpace

Tue, 09/18/18 - 10:14 pm

Pages